The Centers for Medicare & Medicaid Services (CMS) requests Medicare Administrative Contractors (MACs) review revision to the Medicare National Coverage Determinations Manual regarding screening for HBV infection, which will be covered with the appropriate U.S. Food and Drug Administration (FDA) approved/cleared laboratory tests according to Clinical Laboratory Improvement Act (CLIA) regulations.
Subject: Screening for Hepatitis B Virus (HBV) Infection
Release Date: April 28, 2017
Effective Date: September 28, 2016
Implementation Date: October 2, 2017
Special Notes: N/A